Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Frédéric Barbey et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
The Role of Phospholipase D in Modulating the MTOR Signaling Pathway in Polycystic Kidney DiseaseYang Liu, Andreas L. Serra|PLoS ONE|2013Cited by 23